A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee

Clinical trial NCT05931367 · COMPLETED

Trial details

NCT number: NCT05931367
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity Overweight Osteo Arthritis Knee

Start date: 2023-08-01
Primary completion: 2025-11-14
Enrollment: 445

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.